New approaches to management of multiple myeloma. - Wikidata - awgldk - TriplyDB

New approaches to management of multiple myeloma.

New approaches to management of multiple myeloma.

http://www.wikidata.org/entity/Q38191867

about

Nothing Boring About Boron Treatment of multiple myeloma bone disease: experimental and clinical data.Synergistic Activity of Carfilzomib and Panobinostat in Multiple Myeloma Cells via Modulation of ROS Generation and ERK1/2.Arsenic trioxide-based therapy in relapsed/refractory multiple myeloma patients: a meta-analysis and systematic review.Tretatment approach of nontransplant patients with multiple myeloma DNA repair of myeloma plasma cells correlates with clinical outcome: the effect of the nonhomologous end-joining inhibitor SCR7.Increased resistance to proteasome inhibitors in multiple myeloma mediated by cIAP2--implications for a combinatorial treatment.Myeloma cells resistance to NK cell lysis mainly involves an HLA class I-dependent mechanism.Targeting complete response with upfront bortezomib consolidation versus observation after the achievement of complete response following autologous transplantation for multiple myeloma (TUBA study).Diagnosis of Plasma Cell Dyscrasias and Monitoring of Minimal Residual Disease by Multiparametric Flow Cytometry.Cost-effectiveness analysis of treating transplant-eligible multiple myeloma patients in Macedonia.Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma

P2860

Q26771927-372AA050-6999-4F5B-94D2-8A66DC7C663F Q30868833-CEC6B198-F3C0-4B35-A289-A9D59897563B Q35592352-1183D550-5EAE-4EF4-BFB2-69F8969C54D5 Q38253354-83FC27B7-EBD9-42D9-BAAE-886F864913B1 Q38311072-10724820-03AD-42D2-8BC2-D3EA9CBA9D22 Q38756630-25D35FD0-2761-4B8D-AE60-6242FE5E4304 Q38868257-8F2454FC-061C-4180-B1F1-83DB56527C4C Q38992850-8F277AA1-C6C8-4F6C-84B7-49D0407391BA Q47775860-CED656BA-A45E-481B-B8D6-F93EB08AA1A0 Q49641900-D1C81E4E-4D27-4118-93F3-F154862EB0BE Q55359967-72C8A1D0-9C03-4CA8-8223-8564BBA5BCC7 Q58800038-A00BDED9-ED38-4530-BD93-492843ACA1AA

P2860

New approaches to management of multiple myeloma.

http://www.wikidata.org/entity/Q38191867

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

New approaches to management of multiple myeloma.

@en

type

label

New approaches to management of multiple myeloma.

@en

prefLabel

New approaches to management of multiple myeloma.

@en

P1433

Q38191867-35F024DA-4A60-448C-928B-387532DECBA6

P1476

Q38191867-6B5D5139-044B-46FD-BF93-358793305E92

P2093

Q38191867-17DD265B-C10D-4063-AA32-0C85BFF346CA

P2860

Q38191867-0A6AD742-470F-4AFA-AC70-A807C6DD9E42

Q38191867-1407AA21-441E-4DC6-A4AD-F8124F8A0956

Q38191867-19DBDA03-CCCC-436E-ACE1-85ECC2D67DFE

Q38191867-21AD3B18-FA16-42D6-86EA-90B975E9EE88

Q38191867-24765DF9-4BB1-48A1-B14C-F72008011679

Q38191867-26D3A2DB-5B5A-460E-8BB2-F3BB2000E1F4

Q38191867-28EBEBE9-4E7C-44D7-BF15-86BC66C39C20

Q38191867-2EBA8120-0340-4A0D-ABAD-0227AF709CAE

Q38191867-2FD52674-C3A4-4C47-8CFA-492590C8F2FF

Q38191867-32868C75-AB54-4E62-8A48-8700DDF3030C

P2888

Q38191867-E608C274-8388-44E6-9E71-0E245199328F

P304

Q38191867-910B636B-8CAB-4F03-B1A2-40C78571D8F7

P31

Q38191867-86788EF6-B17F-4CA4-9BE5-56E3E31A8626

P356

Q38191867-87F5752E-7B06-4DEF-8109-5BD2FBB34573

P433

Q38191867-333D2B81-7F20-4699-8E0C-B2BAE59DD0E4

P478

Q38191867-7D35112B-0149-4D61-A1A4-D30448DDE7B8

P50

Q38191867-4A7762CD-F727-4267-8128-88D1BD227B7C

Q38191867-74DAF8D3-3E69-49D9-A257-B0103AF807B8

P577

Q38191867-B5B18C57-2E7F-4871-B3A7-93BCD7B6C142

P6179

Q38191867-4FE28DC1-281B-44DF-9EA0-1E13C817DF62

P698

Q38191867-FD84472B-34A7-4454-9D35-C9EE152D11DF

P356

S11864-014-0276-6

P1433

Current Treatment Options in Oncology

P1476

New approaches to management of multiple myeloma

@en

P2093

Sonja Genadieva-Stavric

http://www.w3.org/2001/XMLSchema#string

P2860

Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma

Lenalidomide plus high-dose dexamethasone versus lenalidomide plus low-dose dexamethasone as initial therapy for newly diagnosed multiple myeloma: an open-label randomised controlled trial

Combining fluorescent in situ hybridization data with ISS staging improves risk assessment in myeloma: an International Myeloma Working Group collaborative project.

Pomalidomide (CC4047) plus low-dose dexamethasone as therapy for relapsed multiple myeloma.

Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.

Lenalidomide, bortezomib, and dexamethasone combination therapy in patients with newly diagnosed multiple myeloma.

Practical management of adverse events in multiple myeloma: can therapy be attenuated in older patients?

A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma

A phase I single-agent study of twice-weekly consecutive-day dosing of the proteasome inhibitor carfilzomib in patients with relapsed or refractory multiple myeloma or lymphoma.

A phase 2 study of single-agent carfilzomib (PX-171-003-A1) in patients with relapsed and refractory multiple myeloma.

P2888

s11864-014-0276-6

P304

157-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11864-014-0276-6

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Federica Cavallo

Antonio Palumbo

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1043911836

http://www.w3.org/2001/XMLSchema#string

P698

24578203

http://www.w3.org/2001/XMLSchema#string